Zynex Inc. (ZYXI): Price and Financial Metrics
ZYXI Price/Volume Stats
| Current price | $12.15 | 52-week high | $14.75 |
| Prev. close | $11.96 | 52-week low | $6.88 |
| Day low | $11.87 | Volume | 115,501 |
| Day high | $12.23 | Avg. volume | 245,088 |
| 50-day MA | $12.57 | Dividend yield | N/A |
| 200-day MA | $9.88 | Market Cap | 390.87M |
ZYXI Stock Price Chart Interactive Chart >
Zynex Inc. (ZYXI) Company Bio
Zynex Inc., through its subsidiary, markets electro therapy products which help improve life of patients who have functional disabilities. The Company's products include muscle stimulation, inferential, and TENS devices. Zynex products are intended for home use for stroke rehabilitation, spinal cord injury rehabilitation, incontinence, and other applications.
Latest ZYXI News From Around the Web
Below are the latest news stories about ZYNEX INC that investors may wish to consider to help them evaluate ZYXI as an investment opportunity.
Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov ForumThe post Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum appeared first on CorpGov. |
12 Best Healthcare Stocks For the Long-TermIn this piece, we will take a look at the 12 best healthcare stocks for the long term. If you want to skip our overview of the healthcare industry, then you can take a look at 5 Best Healthcare Stocks For the Long-Term. The healthcare industry is one of the biggest industries in the world. […] |
Healthcare Edge: Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov ForumHealthcare Edge and Exec Edge are please to provide complete video coverage of the third annual Palm Beach CorpGov Forum, which was held on Nov. 8, featuring a full day of panels and fireside chats. The event was composed of over 200 attendees including public and private corporations, private equity and VC funds, institutions, family offices, attorneys, investment bankers, other […] |
Zynex Ranked in Forbes List of "America's Most Successful Small-Cap Companies 2024"Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked within Forbes' list of America's Most Successful Small-Cap Companies for 2024. The 2024 Forbes list of America's Most Successful Small-Cap Companies can be found at www.forbes.com. |
Zynex Submits FDA Application for its Next Generation NMES DeviceZynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical Stimulation ("NMES") device. |
ZYXI Price Returns
| 1-mo | -3.19% |
| 3-mo | 23.23% |
| 6-mo | 58.62% |
| 1-year | 1.76% |
| 3-year | -12.99% |
| 5-year | 151.69% |
| YTD | 11.57% |
| 2023 | -21.71% |
| 2022 | 53.47% |
| 2021 | -25.93% |
| 2020 | 71.03% |
| 2019 | 167.69% |
Continue Researching ZYXI
Here are a few links from around the web to help you further your research on Zynex Inc's stock as an investment opportunity:Zynex Inc (ZYXI) Stock Price | Nasdaq
Zynex Inc (ZYXI) Stock Quote, History and News - Yahoo Finance
Zynex Inc (ZYXI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...